
GLP-1 weight-loss medications linked to improved cancer survival in certain patients
Fox News
New study shows colon cancer patients taking GLP-1 drugs like Ozempic had 15% mortality vs. 37% for non-users over five years, suggesting significant survival benefits.
Melissa Rudy is senior health editor and a member of the lifestyle team at Fox News Digital. Story tips can be sent to melissa.rudy@fox.com.
They found that the patients were much less likely to die within five years than those who weren’t taking the drugs.
More Related News

Ancient silver cup may show world's oldest cosmic creation scene, researcher says: 'Chaos prevailed'
Researchers say they've discovered what may be the oldest depiction of cosmic creation. It appers on a 4,000-year-old silver cup found in a West Bank archaeological site.












